Insider trade

Phathom Pharmaceuticals (PHAT)Director bought ~$44K

Asit Parikh, Director at Phathom Pharmaceuticals, bought ~$44K of Phathom Pharmaceuticals shares.

~$44K
Approx. value · 10K sh @ $4.42: 86K
Holds after · shares reported

Traded: Mar 13, 2025
Filed: Mar 17, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

Jan 21, 2025Insider · 3 peopleInsiders: 3 sales (~$221K)
Mar 13, 2025 · this disclosureInsiderDirector purchased ~$44K of PHAT shares in the open market

What came next

Apr 7, 2025InsiderCFO sold ~$17K of PHAT shares in the open market
May 6, 2025InsiderDirector purchased ~$13K of PHAT shares in the open market
May 7, 2025InsiderDirector purchased ~$12K of PHAT shares in the open market
May 9, 2025Insider · 1 personInsiders: 2 purchases (~$115K)
May 12, 2025InsiderDirector purchased ~$38K of PHAT shares in the open market
May 13, 2025InsiderDirector purchased ~$3.5K of PHAT shares in the open market
May 14, 2025InsiderDirector purchased ~$21K of PHAT shares in the open market
May 21, 2025InsiderDirector purchased ~$15K of PHAT shares in the open market

View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Phathom Pharmaceuticals

OQRO holds no insider, Congress, fund or contract record for Phathom Pharmaceuticals dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its PHAT page.

Other recent filings by Asit Parikh, Director

The full history of Asit Parikh, Director is on the profile page.

How this filing works

Other disclosures at Phathom Pharmaceuticals

Everything OQRO holds on this company is on its PHAT page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO Pro Already have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data